Non-Current Assets

Indefinite-Lived Trademarks

Gilead Sciences Indefinite-Lived Trademarks remained flat by 0.0% to $2.30B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.4%, from $2.89B to $2.30B. Over 2 years (FY 2023 to FY 2025), Indefinite-Lived Trademarks shows a downward trend with a -43.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2015
Last reportedQ1 2026May 7, 2026
Metric ID: indefinite_lived_trademarks

Historical Data

10 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$7.07B$4.64B$4.64B$2.89B$2.89B$2.89B$2.70B$2.70B$2.30B$2.30B
QoQ Change-34.4%+0.0%-37.7%+0.0%+0.0%-6.6%+0.0%-14.8%+0.0%
YoY Change-59.1%-37.7%-41.8%-6.6%-20.4%-20.4%
Range$2.30B$7.07B
CAGR-39.3%
Avg YoY Growth-31.0%
Median YoY Growth-29.1%

Indefinite-Lived Trademarks at Other Companies

Frequently Asked Questions

What is Gilead Sciences's indefinite-lived trademarks?
Gilead Sciences (GILD) reported indefinite-lived trademarks of $2.30B in Q1 2026.
How has Gilead Sciences's indefinite-lived trademarks changed year-over-year?
Gilead Sciences's indefinite-lived trademarks decreased by 20.4% year-over-year, from $2.89B to $2.30B.
What is the long-term trend for Gilead Sciences's indefinite-lived trademarks?
Over 2 years (2023 to 2025), Gilead Sciences's indefinite-lived trademarks has grown at a -43.0% compound annual growth rate (CAGR), from $7.07B to $2.30B.